Vera Juan
Known title: Chief Scientific Officer & COOCIK: 0001755495
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Marker Therapeutics appears in Yahoo's October 16 top picks. Yahoo included Marker Therapeutics in its list of notable stocks for October 16. The mention may increase visibility among investors. The stock is currently near its $1.41 support level and has an RSI of 38.5, suggesting modest momentum.
Transaction History
| KLRS | ▲ Buy | Grant | 35,000 | $0 | 6/6/2024 | View on chart |
| KLRS | ▲ Buy | Grant | 35,000 | $0 | 5/11/2023 | View on chart |
| MRKR | ▲ Buy | Grant | 140,823 | $0 | 3/24/2022 | View on chart |
| MRKR | ▼ Sell | Tax Withholding | 33,465 | $16K | 3/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI
Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.
Kalaris Therapeutics Moves in Pre-Market Amid Low RSI. Kalaris Therapeutics was highlighted in a roundup of health care stocks moving in Wednesday's pre-market session. The stock is currently trading near its 52-week low, with the RSI indicating oversold conditions. Analysts maintain a wide range of price targets for the company, reflecting varying views on its future performance.